All lobbying filings
Frontline Government Relations
Frontline Government Relations filed a Q2 report for Empower Pharmacy on July 15, 2026.
Lobbying for Empower Pharmacy · Compounding pharmacy
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 15, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Texas
Government bodies contacted
3
Lobbying activity
2
Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.